Evidence map›Paper›PMID 35713754›Full record

ArticleInternational journal of clinical oncology2022

Development of a national health policy logic model to accelerate the integration of oncology and palliative care: a nationwide Delphi survey in Japan.

Yu Uneno, Maki Iwai, Naoto Morikawa, Keita Tagami, Yoko Matsumoto, Junko Nozato, Takaomi Kessoku, Tatsunori Shimoi, Miyuki Yoshida, Aya Miyoshi and 7 more

Abstract read
PubMed Publisher
In one paragraph

Article in International journal of clinical oncology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Yu UnenoDepartment of Therapeutic Oncology, Graduate School of Medicine, Kyoto University, Kyoto, 606-8507, Japan.ORCID http://orcid.org/0000-0002-0322-8815
Maki IwaiFormer Non-Profit Organization, Cancer Policy Summit, Tokyo, 155-0032, Japan.
Naoto MorikawaDepartment of Clinical Oncology, Tohoku Rosai Hospital, Sendai, 981-8563, Japan.
Keita TagamiDepartment of Palliative Medicine, Tohoku University Graduate School of Medicine, Sendai, 980-8575, Japan.
Yoko MatsumotoSpecified Non-Profit Organization, Ehime Cancer Support Association Orange, Matsuyama, 790-0023, Japan.
Junko NozatoDepartment of Internal Medicine, Palliative Care, Tokyo Medical and Dental University Hospital, Tokyo, 113-8519, Japan.
Takaomi KessokuDepartment of Palliative Medicine, Yokohama City University Hospital, 3-9 Fukuura, Kanazawa-ku, Yokohama, 236-0004, Japan.
Tatsunori ShimoiDepartment of Medical Oncology, National Cancer Center Hospital, Tokyo, 104-0045, Japan.
Miyuki YoshidaProgram for Nursing and Health Sciences, Graduate School of Medicine, Ehime University, Ehime, 791-0295, Japan.
Aya MiyoshiSpecified Non-Profit Organization, Cancer Support Kagoshima, Kagoshima, 890-8511, Japan.
Ikuko SugiyamaDivision of Nursing, Tohoku University Hospital, Sendai, 980-8574, Japan.
Kazuhiro MantaniCancer Support Centre, National Hospital Organization, Osaka-Minami Medical Center, Osaka, 586-8521, Japan.
Mai ItagakiSection of Research Administration, National Cancer Center Hospital East, Chiba, 277-8577, Japan.
Akemi YamagishiDepartment of Preventive Medicine and Public Health, School of Medicine, Keio University, Tokyo, 160-8582, Japan.
Tatsuya MoritaDepartment of Palliative and Supportive Care, Seirei Mikatahara General Hospital, Hamamatsu, 433-8558, Japan.
Akira InoueDepartment of Palliative Medicine, Tohoku University Graduate School of Medicine, Sendai, 980-8575, Japan. akira.inoue.b2@tohoku.ac.jp.
Manabu MutoDepartment of Therapeutic Oncology, Graduate School of Medicine, Kyoto University, Kyoto, 606-8507, Japan.

Funding

Ministry of Health, Labour and Welfare Health Labor Science Research Grant: Grant number 20EA1009
6 · The paper itself

Abstract

backgroundDespite recommendations to deliver palliative care to cancer patients and their caregivers, their distress has not been alleviated satisfactorily. National health policies play a pivotal role in achieving a comprehensive range of quality palliative care delivery for the public. However, there is no standardised logic model to appraise the efficacy of these policies. This study aimed to develop a logic model of a national health policy to deliver cancer palliative care and to reach consensus towards specific policy proposals.

methodsA draft version of the logic model and specific policy proposals were formulated by the research team and the internal expert panel, and the independent external expert panel evaluated the policy proposals based on the Delphi survey to reach consensus.

resultsThe logic model was divided into three major conceptual categories: 'care-delivery at cancer hospitals', 'community care coordination', and 'social awareness of palliative care'. There were 18 and 45 major and minor policy proposals, which were categorised into four groups: requirement of government-designated cancer hospitals; financial support; Basic Plan to Promote Cancer Control Programs; and others. These policy proposals were independently evaluated by 64 external experts and the first to third Delphi round response rates were 96.9-98.4%. Finally, 47 policy proposals reached consensus. The priority of each proposal was evaluated within the four policy groups.

conclusionsA national health policy logic model was developed to accelerate the provision of cancer palliative care. Further research is warranted to verify the study design to investigate the efficacy of the logic model.

Indexed as

NeoplasmsPalliative CareHealth PolicyHumansJapanLogicCancerEvidence-based policy makingLogic modelNational health policyOncologyPalliative care

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.